Depletion of wolbachia endobacteria in Onchocerca volvulus by doxycycline and microfilaridermia after ivermectin treatment

Lancet

Volumn 357, Issue 9266, 2001, Pages 1415-1416

  Hoerauf, Achim ^a   Mand, Sabine ^a   Adjei, Ohene ^b   Fleischer, Bernhard ^a   Büttner, Dietrich W ^a  

^a BERNHARD NOCHT INSTITUTE FOR TROPICAL MEDICINE   (Germany)

^b KWAME NKRUMAH UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Ghana)

Author keywords

[No Author keywords available]

Indexed keywords

DOXYCYCLINE; IVERMECTIN;

ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE CONTROL; DISEASE TRANSMISSION; DRUG EFFECT; DRUG POTENTIATION; DRUG STERILITY; HUMAN; IMMUNOHISTOLOGY; MICROFILARIASIS; ONCHOCERCA VOLVULUS; ONCHOCERCIASIS; PRIORITY JOURNAL; SKIN NODULE; WOLBACHIA;

EID: 0035810631     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(00)04581-5     Document Type: Article

References (5)

1. Richards F., Hopkins D., Cupp E. Programmatic goals and approaches to onchocerciasis. Lancet. 355:2000;1663-1664.
2. Abiose A., Homeida M., Liese B., Molyneux D., Remme H. Onchocerciasis control strategies. Lancet. 356:2000;1523-1524.
3. Awadzi K., Addy E.T., Opoku N.O., Plenge-Bönig A., Büttner D.W. The chemotherapy of onchocerciasis XX: ivermectin in combination with albendazole. Trop Med Parasitol. 46:1995;213-220.
4. Hoerauf A., Volkmann L., Hamelmann C., et al. Endosymbiotic bacteria in worms as targets for a novel chemotherapy in filariasis. Lancet. 355:2000;1242-1243.
5. Remme J., Ba O., Dadzie K.Y., Karam M. A force-of-infection model for onchocerciasis and its applications in the epidemiological evaluation of the Onchocerciasis Control Programme in the Volta River basin area. Bull World Health Organ. 64:1986;667-681.